Science Explorer Back to mapMap
Discussion
Company · Foster City · United States

Apollomics (United States)

apollomicsinc.comROR OpenAlex
Research works
5
▲ 38% vs 2018-21
Citations
3
0.6 per fractional work
Top-10% rate
8.1%
all institutions 10.0%
Open access
37%
world 40%
International
64%
world 18%
Apollomics (United States)

Not ranked overall: Apollomics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Apollomics (United States) work in?

In all years, 68% of research at Apollomics (United States) is in Health Sciences, 29% in Life Sciences. Its largest fields are Medicine (68%), Biochemistry, Genetics and Molecular Biology (15%), Immunology and Microbiology (13%). It does 1.5× the world's share of Health Sciences.

Health Sciences: 3 fractional works · 68.3% of its workMedicine: 3 fractional works · 68.3% of its workPulmonary and Respiratory Medicine: 1 fractional works · 21.3% of its workHepatology: 1 fractional works · 13.4% of its workOncology: 1 fractional works · 11.2% of its workPathology and Forensic Medicine: 0 fractional works · 6.5% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 3.7% of its workNeurology: 0 fractional works · 3.3% of its workSurgery: 0 fractional works · 3.3% of its workEpidemiology: 0 fractional works · 2.6% of its workInternal Medicine: 0 fractional works · 2.2% of its workPhysiology: 0 fractional works · 0.6% of its workReproductive Medicine: 0 fractional works · 0.4% of its workLife Sciences: 1 fractional works · 28.5% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 15.4% of its workMolecular Biology: 0 fractional works · 9.1% of its workBiotechnology: 0 fractional works · 3.3% of its workCancer Research: 0 fractional works · 1.6% of its workGenetics: 0 fractional works · 1.0% of its workCell Biology: 0 fractional works · 0.6% of its workImmunology and Microbiology: 1 fractional works · 13.2% of its workImmunology: 1 fractional works · 13.2% of its workPhysical Sciences: 0 fractional works · 3.1% of its workChemistry: 0 fractional works · 1.8% of its workSpectroscopy: 0 fractional works · 1.8% of its workEngineering: 0 fractional works · 1.4% of its workBiomedical Engineering: 0 fractional works · 1.4% of its workALL ITS WORKApollomics(United States)5fractional works, all years
Life Sciences29%Physical Sciences3%Health Sciences68%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Medicine368.3%
    1. Biochemistry, Genetics and Molecular Biology115.4%
    2. Immunology and Microbiology113.2%
    1. Chemistry01.8%
    2. Engineering01.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Apollomics (United States)?

The most cited paper from Apollomics (United States) is "Mass Spectrometry-based Solutions for Single-cell Proteomics" (Siqi Li, Shuwei Li, Siqi Liu et al., 2025), with 10 citations. Next come "Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements" (7) and "Phase 1/2 study of the safety and efficacy of APL-101, a specific c-MET inhibitor" (3).

Most cited papers
#PaperReleasedCitations
1 Mass Spectrometry-based Solutions for Single-cell Proteomics Siqi Li, Shuwei Li, Siqi Liu et al. · Genomics Proteomics & Bioinformatics Open access Feb 2025 10
2 Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements Seshiru Nakazawa et al. · Cancer Discovery 9 Apr 2025 7
3 Phase 1/2 study of the safety and efficacy of APL-101, a specific c-MET inhibitor Sani Haider Kizilbash, A. El-Khoueiry, Richard Lerner et al. · European Journal of Cancer Open access Oct 2020 3
4 1382P Vebreltinib efficacy and safety in NSCLC patients with METex14 skipping mutations Maurice Pérol, Mark Magdi Awad, Siddhartha H. K. Devarakonda et al. · Annals of Oncology Open access Sep 2024 1
5 Enrichment of glycoRNAs using galactose oxidase, hydrazide chemistry, and glycosidase digestion Xinyu Miao, Jianbo Deng, Xiaotong Wang et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 2 Jun 2024 0
All 8 most cited papers, with filters and sorting

Which research topics does Apollomics (United States) publish most on?

By volume in 2022-now: Hepatocellular Carcinoma Treatment and Prognosis, Lung Cancer Treatments and Mutations, Cancer Mechanisms and Therapy and Neurofibromatosis and Schwannoma Cases.

Hepatocellular Carcinoma…0Hepatocellular Carcinoma Treatment and Prognosis: 0 fractional worksLung Cancer Treatments and Mutations: 0 fractional worksCancer Mechanisms and Therapy: 0 fractional worksNeurofibromatosis and Schwannoma Cases: 0 fractional worksSarcoma Diagnosis and Treatment: 0 fractional worksGastric Cancer Managemen…0Gastric Cancer Management and Outcomes: 0 fractional worksLiver physiology and pathology: 0 fractional worksLung Cancer Diagnosis and Treatment: 0 fractional worksPeripheral Artery Disease Management: 0 fractional worksAcute Ischemic Stroke Management: 0 fractional works
HepatologyPulmonary and Respiratory MedicinePathology and Forensic MedicineNeurology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 0 works
  2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  3. 3 Cancer Mechanisms and Therapy Pathology and Forensic Medicine 0 works
  4. 4 Neurofibromatosis and Schwannoma Cases Neurology 0 works
  5. 5 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  6. 6 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
  7. 7 Liver physiology and pathology Hepatology 0 works
  8. 8 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  9. 9 Peripheral Artery Disease Management Surgery 0 works
  10. 10 Acute Ischemic Stroke Management Epidemiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.3%not open62.7%

World: 40% of research is openly available.

with international co-authors64.1%domestic only35.9%

World: 18% is written across borders.

How has Apollomics (United States)'s research output changed?

Output in 2022-2025 was 38% higher than in 2018-2021.

still counting20202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Foster City

All research institutions in Foster City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Apollomics (United States). Posts are plain text and can be reported.